Interventional procedure overview of endoluminal gastroplication for gastro-oesophageal reflux disease
Closed for comments This consultation ended on at Request commenting lead permission
Additional information considered by IPAC
Professional experts' opinions
Expert advice was sought from consultants who have been nominated or ratified by their professional Society or Royal College. The advice received is their individual opinion and is not intended to represent the view of the society. The advice provided by professional experts, in the form of the completed questionnaires, is normally published in full on the NICE website during public consultation, except in circumstances but not limited to, when comments are considered voluminous, or publication would be unlawful or inappropriate.
Three professional expert questionnaires for endoluminal gastroplication for gastro-oesophageal reflux disease were submitted and can be found on the NICE website.
Patient commentators' opinions
NICE's Public Involvement Programme will send questionnaires to NHS trusts for distribution to patients who had the procedure (or their carers). When NICE has received the completed questionnaires, these will be discussed by the committee.
Company engagement
A structured information request was sent to 3 companies who manufacture a potentially relevant device for use in this procedure. NICE received 0 completed submissions.
Issues for consideration by IPAC
Ongoing trials and registries:
- Observational Registry of Transoral Incisionless Fundoplication (TIF) for Gastro-oesophageal Reflux Disease (GORD) (NCT05066594); Observational registry; Italy; estimated enrolment n=100; estimated study completion date May 2029.
- Transoral Incisionless Fundoplication Database Repository (TIF) (NCT04306380); case series; USA; estimated enrolment n=500; estimated study completion date December 2030.
- Endoscopic Fundoplication with MUSE System (NCT03669874); cohort study; Italy; estimated enrolment n=80; estimated study completion date September 2026.
-Multicentre Single-Blind RCT of cTIF Versus LNF For Treatment of GORD in Patients Requiring Hiatal Hernia Repair (NCT04795934); RCT; USA; estimated enrolment n=142; estimated study completion date December 2026.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions